Panama’s National Directorate of Pharmacy and Drugs has issued an alert regarding the circulation of counterfeit Mounjaro medication. Authorities clarified that the falsified product in question is not registered for use within Panama. The Ministry of Health is urging citizens to avoid purchasing Mounjaro through unofficial or irregular channels to protect their health. This warning comes as concerns rise about the potential dangers of using substandard or fake pharmaceuticals. The directorate emphasized the importance of only obtaining medication from legitimate pharmacies and healthcare providers. Consumers are advised to verify the authenticity of any medicine before use. Further investigations are underway to identify the source of the counterfeit drugs.